Poor association of allergen‐specific antibody, T‐ and B‐cell responses revealed with recombinant allergens and a CFSE dilution‐based assay

Background The adaptive immunity underlying allergy comprises two components, the allergen‐specific antibody (i.e. IgE, IgG) and the T‐cell response. These two components are responsible for different disease manifestations and can be targeted by different therapeutic approaches. Here, we investigated the association of allergen‐specific antibody and T‐ as well as B‐cell responses in pollen‐allergic patients using recombinant (r) major birch pollen allergen rB et v 1 and major timothy grass pollen allergen rP hl p 5 as defined antigens. Methods Allergen‐specific IgE and IgG antibody responses were determined by ELISA , and allergen‐specific T‐ and B‐cell responses were measured in peripheral blood mononuclear cells using a carboxyfluorescein‐diacetate‐succinimidylester ( CFSE ) dilution assay. Results CFSE staining in combination with T‐cell‐ and B‐cell‐specific gating allowed discriminating between allergen‐specific T‐cell and B‐cell responses. Interestingly, we identified patients where mainly T cells and others where mainly B cells proliferated in response to allergen stimulation. No association between the level of allergen‐specific Ig responses and B‐ or T‐cell proliferation was observed. Conclusion Purified recombinant allergens in conjunction with CFSE staining allow the dissection of allergen‐specific B‐ and T‐cell responses. The dissociation of allergen‐specific antibody, and B‐ and T‐cell responses may explain the occurrence of selective IgE‐ and T‐cell‐mediated manifestations of allergic inflammation and may be important for the development of diagnostic and therapeutic strategies selectively targeting B cells and T cells.